<?xml version="1.0" encoding="UTF-8"?>
<p>According to the International Association for the Study of Pain (IASP), inflammatory and neuropathic pain are unpleasant and incapacitant conditions that impair the quality of life of those who suffer from that condition. The pathological origins of inflammatory and neuropathic pain are different—inflammatory pain is produced by a lesion in tissue [
 <xref rid="B1-plants-10-00865" ref-type="bibr">1</xref>], whereas neuropathic pain is a consequence of a lesion or disease affecting the somatosensory system [
 <xref rid="B2-plants-10-00865" ref-type="bibr">2</xref>,
 <xref rid="B3-plants-10-00865" ref-type="bibr">3</xref>]. Both inflammatory and neuropathic conditions are commonly represented as chronic pain when the pain lasts or recurs for longer than 3 months [
 <xref rid="B4-plants-10-00865" ref-type="bibr">4</xref>]. In this way, chronic pain is considered a big problem for the politics of health in developing and developed countries [
 <xref rid="B5-plants-10-00865" ref-type="bibr">5</xref>]. The prevalence of moderate–severely disabling chronic pain has been estimated to be between 10.4% to 14.3% [
 <xref rid="B6-plants-10-00865" ref-type="bibr">6</xref>].
</p>
